Cooperative Agreement to Support the Food and Agriculture Organization (FAO) (U01)
(RFA-FD-18-009)
Food and Drug Administration
Application Receipt Date(s):
July 2, 2018, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.

Enhancing Innovations in Emerging Technologies for Advanced Manufacturing of Complex Biologic Products (R01)
(RFA-FD-18-023)
Food and Drug Administration
Application Receipt Date(s):
June 25, 2018, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.

Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed)
(RFA-HG-18-001)
National Human Genome Research Institute
Application Receipt Date(s):
June 27, 2018; June 27, 2019; June 26, 2020), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed)
(RFA-HG-18-002)
National Human Genome Research Institute
Application Receipt Date(s):
June 27, 2018; June 27, 2019; June 26, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Summer Institute for Research Education in Biostatistics (R25 - Clinical Trials Not Allowed)
(RFA-HL-19-019)
National Heart, Lung, and Blood Institute
Application Receipt Date(s):
June 28, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed)
(RFA-NS-18-030)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and BioengineeringEunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Office of Behavioral and Social Science Research
Office of Research on Women's Health
Application Receipt Date(s):
July 3, 2018; N?o?v?e?m?b?e?r? ?6, 2018; July 3, 2019; November 6, 2019; July 1, 2020; November 10, 2020by 5:00 PM local time of applicant organization.All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

In Vivo Synaptic Function in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)
(PAR-18-760)
National Institute on Aging
Application Receipt Date(s):
Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)
(PAR-18-764)
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute of Mental Health
Application Receipt Date(s):
Standard AIDS dates, by 5:00 PM local time of applicant organization. All types of AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.